The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Non-Hodgkin Lymphoma: Diagnosis and Treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationCancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Report of the Committee on Hodgkin's Disease Staging Classification.
Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W., & Tubiana, M. (1971) · PubMed · Cited by 4,166
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationHans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411087 · Cited by 3,560
Self-citationCesarman, E., Chang, Y., Moore, P. S., Said, J. W., & Knowles, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321802 · Cited by 2,818
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332305 · Cited by 2,439
Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C. T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-68 · Cited by 2,428
Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A., & Miller, T. P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304083281404 · Cited by 2,149
Pfreundschuh, M., Trümper, L., Österborg, A., Pettengell, R., Trneny, M., Imrie, K., Ma, D., Gill, D., Walewski, J., Zinzani, P.-L., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70664-7 · Cited by 2,076
Helicobacter pylori Infection and Gastric Lymphoma
Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich, N., Vogelman, J. H., & Friedman, G. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301803 · Cited by 1,831
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Self-citationTargeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306220 · Cited by 1,685
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Younes, A., Gopal, A. K., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Ramchandren, R., Bartlett, N. L., Cheson, B. D., de Vos, S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0410 · Cited by 1,529
Self-citationRummel, M. J., Niederle, N., Maschmeyer, G., Banat, G. A., von Grünhagen, U., Losem, C., Kofahl-Krause, D., Heil, G., Welslau, M., Balser, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61763-2 · Cited by 1,510
Feugier, P., Van Hoof, A., Sebban, C., Solal-Celigny, P., Bouabdallah, R., Fermé, C., Christian, B., Lepage, E., Tilly, H., Morschhauser, F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.131 · Cited by 1,486
Sehn, L. H., Berry, B., Chhanabhai, M., Fitzgerald, C., Gill, K., Hoskins, P., Klasa, R., Savage, K. J., Shenkier, T., Sutherland, J., et al. (2007) · Blood · doi:10.1182/blood-2006-08-038257 · Cited by 1,473
Dave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,418
Self-citationBrentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002965 · Cited by 1,368
Habermann, T. M., Weller, E. A., Morrison, V. A., Gascoyne, R. D., Cassileth, P. A., Cohn, J. B., Dakhil, S. R., Woda, B., Fisher, R. I., Peterson, B. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1003 · Cited by 1,355
Follicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
Canellos, G. P., Anderson, J. R., Propert, K. J., Nissen, N., Cooper, M. R., Henderson, E. S., Green, M. R., Gottlieb, A., & Peterson, B. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272102 · Cited by 1,148
Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A. M., Haenel, M., Boissevain, F., Zschaber, R., Müller, P., Kirchner, H., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08938-9 · Cited by 1,140
Pfreundschuh, M., Schubert, J., Ziepert, M., Schmits, R., Mohren, M., Lengfelder, E., Reiser, M., Nickenig, C., Clemens, M., Peter, N., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70002-0 · Cited by 1,130
Advani, R. H., Buggy, J. J., Sharman, J. P., Smith, S. M., Boyd, T. E., Grant, B., Kolibaba, K. S., Furman, R. R., Rodriguez, S., Chang, B. Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7906 · Cited by 1,128
Rosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P., Gascoyne, R. D., Chan, W. C., Zhao, T., Haioun, C., Greiner, T. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031074 · Cited by 1,101
Self-citationSalles, G., Seymour, J. F., Offner, F., López-Guillermo, A., Belada, D., Xerri, L., Feugier, P., Bouabdallah, R., Catalano, J. V., Brice, P., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62175-7 · Cited by 1,079
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Gopal, A. K., Kahl, B. S., de Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., Flinn, I. W., Flowers, C. R., Martin, P., Viardot, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314583 · Cited by 1,069
Linch, D. C., Goldstone, A. H., McMillan, A., Chopra, R., Vaughan Hudson, G., Winfield, D., Hancock, B., Moir, D., & Milligan, D. (1993) · The Lancet · doi:10.1016/0140-6736(93)92411-l · Cited by 1,051
Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Spier, C. M., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E., & Fisher, R. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390104 · Cited by 1,004
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
Rai, K. R., Peterson, B. L., Appelbaum, F. R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G. A., Larson, R. A., Cheson, B. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432402 · Cited by 1,001
Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K., Klasa, R., MacPherson, N., O'Reilly, S., Spinelli, J. J., Sutherland, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.137 · Cited by 987
Marcus, R. (2005) · Blood · doi:10.1182/blood-2004-08-3175 · Cited by 967
Mechanisms of B-cell lymphoma pathogenesis
Küppers, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1589 · Cited by 965
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000067 · Cited by 928
Khouri, I. F., Keating, M., Körbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., von Wolff, B., Gajewski, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2817 · Cited by 919
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas
Horning, S. J., & Rosenberg, S. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412063112303 · Cited by 909
Molecular Diagnosis of Burkitt's Lymphoma
Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E.-J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055759 · Cited by 897
Self-citationGallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Betts, P., Mokry, B., Risser, D. R., Weiss, N. S., Williams, M. A., Sjoberg, E., Clanton, M. S., Frankel, L. S., Foxhall, L. E., Hancock, L. E., et al. (2004) · Cited by 840
Diehl, V., Franklin, J., Pfreundschuh, M., Lathan, B., Paulus, U., Hasenclever, D., Tesch, H., Herrmann, R., Dörken, B., Müller-Hermelink, H.-K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022473 · Cited by 838
Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma
McKelvey, E. M., Gottlieb, J. A., Wilson, H. E., Haut, A., Talley, R. W., Stephens, R., Lane, M., Gamble, J. F., Jones, S. E., Grozea, P. N., et al. (1976) · Cancer · doi:10.1002/1097-0142(197610)38:4<1484::aid-cncr2820380407>3.0.co;2-i · Cited by 820
Hermine, O., Lefrère, F., Bronowicki, J.-P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013376 · Cited by 807
Philip, T., Armitage, J. O., Spitzer, G., Chauvin, F., Jagannath, S., Cahn, J.-Y., Colombat, P., Goldstone, A. H., Gorin, N. C., Flesh, M., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162401 · Cited by 771
Self-citationResults of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
Radford, J., Illidge, T., Counsell, N., Hancock, B., Pettengell, R., Johnson, P., Wimperis, J., Culligan, D., Popova, B., Smith, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408648 · Cited by 762
Federico, M., Bellei, M., Marcheselli, L., Luminari, S., Lopez-Guillermo, A., Vitolo, U., Pro, B., Pileri, S., Pulsoni, A., Soubeyran, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3991 · Cited by 751
Friedberg, J. W., Sharman, J., Sweetenham, J., Johnston, P. B., Vose, J. M., LaCasce, A., Schaefer-Cutillo, J., De Vos, S., Sinha, R., Leonard, J. P., et al. (2010) · Blood · doi:10.1182/blood-2009-08-236471 · Cited by 747
Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A. G., Rosenberg, H. M., Feigal, E. G., & Edwards, B. K. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.824 · Cited by 738
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
Kaminski, M. S., Tuck, M., Estes, J., Kolstad, A., Ross, C. W., Zasadny, K., Regan, D., Kison, P., Fisher, S., Kroll, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041511 · Cited by 716
Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4223 · Cited by 680
Aukema, S. M., Siebert, R., Schuuring, E., van Imhoff, G. W., Kluin-Nelemans, H. C., Boerma, E.-J., & Kluin, P. M. (2011) · Blood · doi:10.1182/blood-2010-09-297879 · Cited by 678
Anderson, J. R., Armitage, J. O., & Weisenburger, D. D. (1998) · Annals of Oncology · doi:10.1023/a:1008265532487 · Cited by 674
Self-citationGribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111283252201 · Cited by 668
MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma
KLIMO, P., & CONNORS, J. M. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-5-596 · Cited by 664
Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
Opelz, G., & Henderson, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80084-4 · Cited by 648
Brice, P., Bastion, Y., Lepage, E., Brousse, N., Haïoun, C., Moreau, P., Straetmans, N., Tilly, H., Tabah, I., & Solal-Céligny, P. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1110 · Cited by 647
O'Connor, O. A., Pro, B., Pinter-Brown, L., Bartlett, N., Popplewell, L., Coiffier, B., Jo Lechowicz, M., Savage, K. J., Shustov, A. R., Gisselbrecht, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.9024 · Cited by 647
Flinn, I. W., van der Jagt, R., Kahl, B. S., Wood, P., Hawkins, T. E., MacDonald, D., Hertzberg, M., Kwan, Y.-L., Simpson, D., Craig, M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-531327 · Cited by 643
Engert, A., Haverkamp, H., Kobe, C., Markova, J., Renner, C., Ho, A., Zijlstra, J., Král, Z., Fuchs, M., Hallek, M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61940-5 · Cited by 635
Follicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
van Oers, M. H. J., Klasa, R., Marcus, R. E., Wolf, M., Kimby, E., Gascoyne, R. D., Jack, A., van't Veer, M., Vranovsky, A., Holte, H., et al. (2006) · Blood · doi:10.1182/blood-2006-05-021113 · Cited by 592
Jerusalem, G., Beguin, Y., Fassotte, M. F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999) · Blood · doi:10.1182/blood.v94.2.429 · Cited by 565
Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas
Ferreri, A. J. M., Guidoboni, M., Ponzoni, M., De Conciliis, C., Dell'Oro, S., Fleischhauer, K., Caggiari, L., Lettini, A. A., Dal Cin, E., Ieri, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh102 · Cited by 563
Cunningham, D., Hawkes, E. A., Jack, A., Qian, W., Smith, P., Mouncey, P., Pocock, C., Ardeshna, K. M., Radford, J. A., McMillan, A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60313-x · Cited by 561
Barrans, S., Crouch, S., Smith, A., Turner, K., Owen, R., Patmore, R., Roman, E., & Jack, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3947 · Cited by 552
Groves, F. D., Linet, M. S., Travis, L. B., & Devesa, S. S. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1240 · Cited by 526
Kaminski, M. S., Estes, J., Zasadny, K. R., Francis, I. R., Ross, C. W., Tuck, M., Regan, D., Fisher, S., Gutierrez, J., Kroll, S., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1259 · Cited by 525
Treatment of Older Patients with Mantle-Cell Lymphoma
Kluin-Nelemans, H. C., Hoster, E., Hermine, O., Walewski, J., Trneny, M., Geisler, C. H., Stilgenbauer, S., Thieblemont, C., Vehling-Kaiser, U., Doorduijn, J. K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200920 · Cited by 520
Thieblemont, C., Berger, F., Dumontet, C., Moullet, I., Bouafia, F., Felman, P., Salles, G., & Coiffier, B. (2000) · Blood · doi:10.1182/blood.v95.3.802.003k19_802_806 · Cited by 518
Mounier, N. (2003) · Blood · doi:10.1182/blood-2002-11-3442 · Cited by 513
Multiple Recurrent Genomic Defects in Follicular Lymphoma
Yunis, J. J., Frizzera, G., Oken, M. M., McKenna, J., Theologides, A., & Arnesen, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160204 · Cited by 505
T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma
Streubel, B., Lamprecht, A., Dierlamm, J., Cerroni, L., Stolte, M., Ott, G., Raderer, M., & Chott, A. (2003) · Blood · doi:10.1182/blood-2002-09-2963 · Cited by 493
Duggan, D. B., Petroni, G. R., Johnson, J. L., Glick, J. H., Fisher, R. I., Connors, J. M., Canellos, G. P., & Peterson, B. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.086 · Cited by 487
ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE
Devita, V., Canellos, G., Chabner, B., Schein, P., Hubbard, S., & Young, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91142-3 · Cited by 484
Gianni, A. M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361804 · Cited by 470
Engert, A., Schiller, P., Josting, A., Herrmann, R., Koch, P., Sieber, M., Boissevain, F., de Wit, M., Mezger, J., Dühmke, E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.023 · Cited by 460
Morschhauser, F., Radford, J., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A., d’Amore, F., Diaz, M. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2015 · Cited by 460
Zucca, E., Conconi, A., Mughal, T. I., Sarris, A. H., Seymour, J. F., Vitolo, U., Klasa, R., Ozsahin, M., Mead, G. M., Gianni, M. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.141 · Cited by 444
Mak, V., Hamm, J., Chhanabhai, M., Shenkier, T., Klasa, R., Sehn, L. H., Villa, D., Gascoyne, R. D., Connors, J. M., & Savage, K. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.7524 · Cited by 437
Follicular lymphoma: prognostic factors for response and survival.
Gallagher, C. J., Gregory, W. M., Jones, A. E., Stansfeld, A. G., Richards, M. A., Dhaliwal, H. S., Malpas, J. S., & Lister, T. A. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.10.1470 · Cited by 425
Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Coiffier, B., Brice, P., Bosly, A., Morel, P., Nouvel, C., Tilly, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3025 · Cited by 421
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
Viviani, S., Zinzani, P. L., Rambaldi, A., Brusamolino, E., Levis, A., Bonfante, V., Vitolo, U., Pulsoni, A., Liberati, A. M., Specchia, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100340 · Cited by 420
Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma
Hainsworth, J. D., Litchy, S., Burris, H. A., Scullin, D. C., Corso, S. W., Yardley, D. A., Morrissey, L., & Greco, F. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.674 · Cited by 416
ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
Meyer, R. M., Gospodarowicz, M. K., Connors, J. M., Pearcey, R. G., Wells, W. A., Winter, J. N., Horning, S. J., Dar, A. R., Shustik, C., Stewart, D. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111961 · Cited by 406
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
Conconi, A. (2003) · Blood · doi:10.1182/blood-2002-11-3496 · Cited by 402
Ardeshna, K. M., Qian, W., Smith, P., Braganca, N., Lowry, L., Patrick, P., Warden, J., Stevens, L., Pocock, C. F. E., Miall, F., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70027-0 · Cited by 395
Juweid, M. E., Wiseman, G. A., Vose, J. M., Ritchie, J. M., Menda, Y., Wooldridge, J. E., Mottaghy, F. M., Rohren, E. M., Blumstein, N. M., Stolpen, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.891 · Cited by 387
New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma
Fisher, R. I., LeBlanc, M., Press, O. W., Maloney, D. G., Unger, J. M., & Miller, T. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1674 · Cited by 375
Camilleri-Broët, S., Crinière, E., Broët, P., Delwail, V., Mokhtari, K., Moreau, A., Kujas, M., Raphaël, M., Iraqi, W., Sautès-Fridman, C., et al. (2006) · Blood · doi:10.1182/blood-2005-03-1024 · Cited by 371
Batchelor, T., & Loeffler, J. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8819 · Cited by 362
Diehl, V., Sextro, M., Franklin, J., Hansmann, M.-L., Harris, N., Jaffe, E., Poppema, S., Harris, M., Franssila, K., van Krieken, J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.776 · Cited by 360
Nowakowski, G. S., LaPlant, B., Macon, W. R., Reeder, C. B., Foran, J. M., Nelson, G. D., Thompson, C. A., Rivera, C. E., Inwards, D. J., Micallef, I. N., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5714 · Cited by 359
Self-citationRécher, C., Coiffier, B., Haioun, C., Molina, T. J., Fermé, C., Casasnovas, O., Thiéblemont, C., Bosly, A., Laurent, G., Morschhauser, F., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61040-4 · Cited by 355
Barrington, S. F., Qian, W., Somer, E. J., Franceschetto, A., Bagni, B., Brun, E., Almquist, H., Loft, A., Højgaard, L., Federico, M., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1490-5 · Cited by 348
Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors
Bosch, F., L�pez-Guillermo, A., Campo, E., Ribera, J. M., Conde, E., Piris, M. A., Vallesp�, T., Woessner, S., & Montserrat, E. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980201)82:3<567::aid-cncr20>3.0.co;2-z · Cited by 346
Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma
Stiff, P. J., Unger, J. M., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301077 · Cited by 343
Mack, T. M., Cozen, W., Shibata, D. K., Weiss, L. M., Nathwani, B. N., Hernandez, A. M., Taylor, C. R., Hamilton, A. S., Deapen, D. M., & Rappaport, E. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502163320701 · Cited by 342
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
Martin, P., Chadburn, A., Christos, P., Weil, K., Furman, R. R., Ruan, J., Elstrom, R., Niesvizky, R., Ely, S., DiLiberto, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6121 · Cited by 339
BAGLEY, C. M., DEVITA, V. T., BERARD, C. W., & CANELLOS, G. P. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-2-227 · Cited by 336
Link, B. K., Maurer, M. J., Nowakowski, G. S., Ansell, S. M., Macon, W. R., Syrbu, S. I., Slager, S. L., Thompson, C. A., Inwards, D. J., Johnston, P. B., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.3990 · Cited by 335
Self-citationACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma
Reyes, F., Lepage, E., Ganem, G., Molina, T. J., Brice, P., Coiffier, B., Morel, P., Ferme, C., Bosly, A., Lederlin, P., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042040 · Cited by 324
Gribben, J. G., Neuberg, D. S., Freedman, A. S., Gimmi, C., Pesek, K., Barber, M., Saporito, L., Woo, S., Coral, F., & Spector, N. (1993) · Blood · doi:10.1182/blood.v81.12.3449.3449 · Cited by 323
Peniket, A. J., Ruiz de Elvira, M. C., Taghipour, G., Cordonnier, C., Gluckman, E., de Witte, T., Santini, G., Blaise, D., Greinix, H., Ferrant, A., et al. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703891 · Cited by 322
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
Wündisch, T., Thiede, C., Morgner, A., Dempfle, A., Günther, A., Liu, H., Ye, H., Du, M.-Q., Kim, T. D., Bayerdörffer, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3903 · Cited by 317
von Tresckow, B., Plütschow, A., Fuchs, M., Klimm, B., Markova, J., Lohri, A., Kral, Z., Greil, R., Topp, M. S., Meissner, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5807 · Cited by 314
Gordon, L. I., Hong, F., Fisher, R. I., Bartlett, N. L., Connors, J. M., Gascoyne, R. D., Wagner, H., Stiff, P. J., Cheson, B. D., Gospodarowicz, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4803 · Cited by 308
Iqbal, J., Neppalli, V. T., Wright, G., Dave, B. J., Horsman, D. E., Rosenwald, A., Lynch, J., Hans, C. P., Weisenburger, D. D., Greiner, T. C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4264 · Cited by 298
Self-citationUtility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma
Hehn, S. T., Grogan, T. M., & Miller, T. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.104 · Cited by 292
Witzig, T. E., White, C. A., Gordon, L. I., Wiseman, G. A., Emmanouilides, C., Murray, J. L., Lister, J., & Multani, P. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.043 · Cited by 289
Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden
Coté, T. R., Biggar, R. J., Rosenberg, P. S., Devesa, S. S., Percy, C., Yellin, F. J., Lemp, G., Hardy, C., Geodert, J. J., Blattner, W. A., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971127)73:5<645::aid-ijc6>3.0.co;2-x · Cited by 287
Gisselbrecht, C., Schmitz, N., Mounier, N., Singh Gill, D., Linch, D. C., Trneny, M., Bosly, A., Milpied, N. J., Radford, J., Ketterer, N., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.9416 · Cited by 284
Hochster, H., Weller, E., Gascoyne, R. D., Habermann, T. M., Gordon, L. I., Ryan, T., Zhang, L., Colocci, N., Frankel, S., & Horning, S. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1561 · Cited by 276
van Besien, K., Ha, C. S., Murphy, S., McLaughlin, P., Rodriguez, A., Amin, K., Forman, A., Romaguera, J., Hagemeister, F., Younes, A., et al. (1998) · Blood · doi:10.1182/blood.v91.4.1178 · Cited by 275
Federico, M., Luminari, S., Iannitto, E., Polimeno, G., Marcheselli, L., Montanini, A., La Sala, A., Merli, F., Stelitano, C., Pozzi, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0910 · Cited by 274
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma
Romaguera, J. E., Medeiros, L. J., Hagemeister, F. B., Fayad, L. E., Rodriguez, M. A., Pro, B., Younes, A., McLaughlin, P., Goy, A., Sarris, A. H., et al. (2003) · Cancer · doi:10.1002/cncr.11096 · Cited by 269
Helicobacter and gastric MALT lymphoma
Stolte, M., Bayerdörffer, E., Morgner, A., Alpen, B., Wündisch, T., Thiede, C., & Neubauer, A. (2002) · Gut · doi:10.1136/gut.50.suppl_3.iii19 · Cited by 265
Winter, J. N. (2006) · Blood · doi:10.1182/blood-2005-10-4222 · Cited by 265
Hagenbeek, A., Gadeberg, O., Johnson, P., Møller Pedersen, L., Walewski, J., Hellmann, A., Link, B. K., Robak, T., Wojtukiewicz, M., Pfreundschuh, M., et al. (2008) · Blood · doi:10.1182/blood-2007-10-117671 · Cited by 264
Fowler, N. H., Davis, R. E., Rawal, S., Nastoupil, L., Hagemeister, F. B., McLaughlin, P., Kwak, L. W., Romaguera, J. E., Fanale, M. A., Fayad, L. E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70455-3 · Cited by 264
Younes, A., Sureda, A., Ben-Yehuda, D., Zinzani, P. L., Ong, T.-C., Prince, H. M., Harrison, S. J., Kirschbaum, M., Johnston, P., Gallagher, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.1350 · Cited by 263
Younes, A., Thieblemont, C., Morschhauser, F., Flinn, I., Friedberg, J. W., Amorim, S., Hivert, B., Westin, J., Vermeulen, J., Bandyopadhyay, N., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70311-0 · Cited by 254
t(11;18)(q21;q21) is the most common translocation in MALT lymphomas
Auer, I. A., Gascoyne, R. D., Conners, J. M., Cotter, F. E., Greiner, T. C., Sanger, W. G., & Horsman, D. E. (1997) · Annals of Oncology · doi:10.1023/a:1008202303666 · Cited by 253
Romaguera, J. E., Fayad, L. E., Feng, L., Hartig, K., Weaver, P., Rodriguez, M. A., Hagemeister, F. B., Pro, B., McLaughlin, P., Younes, A., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08228.x · Cited by 245
Fisher, R. I., Kaminski, M. S., Wahl, R. L., Knox, S. J., Zelenetz, A. D., Vose, J. M., Leonard, J. P., Kroll, S., Goldsmith, S. J., & Coleman, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.9217 · Cited by 240
The Epstein–Barr virus and the pathogenesis of lymphoma
Vockerodt, M., Yap, L., Shannon‐Lowe, C., Curley, H., Wei, W., Vrzalikova, K., & Murray, P. G. (2015) · The Journal of Pathology · doi:10.1002/path.4459 · Cited by 230
Sorror, M. L., Maris, M. B., Sandmaier, B. M., Storer, B. E., Stuart, M. J., Hegenbart, U., Agura, E., Chauncey, T. R., Leis, J., Pulsipher, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.569 · Cited by 230
Tirelli, U., Errante, D., Dolcetti, R., Gloghini, A., Serraino, D., Vaccher, E., Franceschi, S., Boiocchi, M., & Carbone, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1758 · Cited by 229
Santoro, A., Bredenfeld, H., Devizzi, L., Tesch, H., Bonfante, V., Viviani, S., Fiedler, F., Parra, H. S., Benoehr, C., Pacini, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2615 · Cited by 229
Rizvi, M. A., Evens, A. M., Tallman, M. S., Nelson, B. P., & Rosen, S. T. (2006) · Blood · doi:10.1182/blood-2005-03-1306 · Cited by 223
Pfreundschuh, M., Ho, A. D., Cavallin-Stahl, E., Wolf, M., Pettengell, R., Vasova, I., Belch, A., Walewski, J., Zinzani, P.-L., Mingrone, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70078-0 · Cited by 221
Lee, A. M., Clear, A. J., Calaminici, M., Davies, A. J., Jordan, S., MacDougall, F., Matthews, J., Norton, A. J., Gribben, J. G., Lister, T. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4642 · Cited by 220
Longo, D. L., DeVita, V. T., Duffey, P. L., Wesley, M. N., Ihde, D. C., HUBBARD, S. M., Gilliom, M., Jaffe, E. S., Cossman, J., & Fisher, R. I. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.1.25 · Cited by 218
van Kampen, R. J. W., Canals, C., Schouten, H. C., Nagler, A., Thomson, K. J., Vernant, J.-P., Buzyn, A., Boogaerts, M. A., Luan, J.-J., Maury, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2596 · Cited by 213
1 The epidemiology of Hodgkin's disease
Glaser, S. L., & Jarrett, R. F. (1996) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(96)80018-7 · Cited by 207
Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas.
Rosenberg, S. A. (1977) · PubMed · Cited by 205
Skoetz, N., Trelle, S., Rancea, M., Haverkamp, H., Diehl, V., Engert, A., & Borchmann, P. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70341-3 · Cited by 204
Jérusalem, G., Beguin, Y. P., Fassotte, M., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001) · PubMed · Cited by 204
Kahl, B. S., Hong, F., Williams, M. E., Gascoyne, R. D., Wagner, L. I., Krauss, J. C., Habermann, T. M., Swinnen, L. J., Schuster, S. J., Peterson, C. G., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.5853 · Cited by 195
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
Fehniger, T. A., Larson, S., Trinkaus, K., Siegel, M. J., Cashen, A. F., Blum, K. A., Fenske, T. S., Hurd, D. D., Goy, A., Schneider, S. E., et al. (2011) · Blood · doi:10.1182/blood-2011-07-362475 · Cited by 191
Apostolidis, J., Gupta, R. K., Grenzelias, D., Johnson, P. W. M., Pappa, V. I., Summers, K. E., Salam, A., Adams, K., Norton, A. J., Amess, J. A. L., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.527 · Cited by 181
The role of positron emission tomography (PET) in the management of lymphoma patients
Zinzani, P. L., Magagnoli, M., Chierichetti, F., Zompatori, M., Garraffa, G., Bendandi, M., Gherlinzoni, F., Cellini, C., Stefoni, V., Ferlin, G., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008327127033 · Cited by 180
Changing incidence of non‐Hodgkin lymphomas in the United States
Clarke, C. A., & Glaser, S. L. (2002) · Cancer · doi:10.1002/cncr.10403 · Cited by 173
Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma
Smalley, R. V., Andersen, J. W., Hawkins, M. J., Bhide, V., O'Connell, M. J., Oken, M. M., & Borden, E. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211053271902 · Cited by 173
Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma
Rohatiner, A. Z. S., Gregory, W. M., Peterson, B., Borden, E., Solal-Celigny, P., Hagenbeek, A., Fisher, R. I., Unterhalt, M., Arranz, R., Chisesi, T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.146 · Cited by 170
Hodgkin’s Lymphoma: Biology and Treatment Strategies for Primary, Refractory, and Relapsed Disease
Diehl, V., Stein, H., Hummel, M., Zollinger, R., & Connors, J. M. (2003) · Hematology · doi:10.1182/asheducation-2003.1.225 · Cited by 169
Viviani, S., Bonadonna, G., Santoro, A., Bonfante, V., Zanini, M., Devizzi, L. F., Soncini, F., & Valagussa, P. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1421 · Cited by 168
Morschhauser, F., Leonard, J. P., Fayad, L., Coiffier, B., Petillon, M.-O., Coleman, M., Schuster, S. J., Dyer, M. J. S., Horne, H., Teoh, N., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9117 · Cited by 164
Armitage, J. O., Weisenburger, D. D., Hutchins, M., Moravec, D. F., Dowling, M., Sorensen, S., Mailliard, J., Okerbloom, J., Johnson, P. S., & Howe, D. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.2.160 · Cited by 164
Self-citationGuadagnolo, B. A., Li, S., Neuberg, D., Ng, A., Hua, L., Silver, B., Stevenson, M. A., & Mauch, P. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.08.010 · Cited by 159
Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia.
Smith, M. R., & Greene, W. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115078 · Cited by 148
Ansell, S. M., Witzig, T. E., Kurtin, P. J., et al. (2002) · Blood · doi:10.1182/blood.v99.1.67 · Cited by 148
Self-citationVose, J. M., Bierman, P., Anderson, J., Kessinger, A., Pierson, J. L., Nelson, J., Frappier, B., Schmit-Pokorny, K. A., Weisenburger, D. D., & Armitage, J. O. (1992) · Blood · doi:10.1182/blood.v80.8.2142.2142 · Cited by 147
Self-citationKluin‐Nelemans, H. C., Zagonel, V., Anastasopoulou, A., Bron, D., Roozendaal, K. J., Noordijk, E. M., Musson, H., Teodorovic, I., Maes, B., Carbone, A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.22 · Cited by 146
Bierman, P. J., Sweetenham, J. W., Loberiza, F. R., Taghipour, G., Lazarus, H. M., Rizzo, J. D., Schmitz, N., van Besien, K., Vose, J. M., Horowitz, M. M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.054 · Cited by 146
Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection
Yood, M. U., Quesenberry, C. P., Guo, D., Caldwell, C. A., Wells, K. E., Shan, J., Sanders, L., Skovron, M. L., Iloeje, U. H., & Manos, M. M. (2007) · Hepatology · doi:10.1002/hep.21642 · Cited by 144
Rehwald, U., Schulz, H., Reiser, M., Sieber, M., Staak, J. O., Morschhauser, F., Driessen, C., Rüdiger, T., Müller-Hermelink, K., Diehl, V., et al. (2002) · Blood · doi:10.1182/blood.v101.2.420 · Cited by 143
Friedberg, J. W., Neuberg, D. S., Gribben, J. G., Fisher, D. C., Canning, C. M., Koval, M. A., Poor, C. M., Green, L. M., Daley, J. F., Soiffer, R. J., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03535.x · Cited by 140
Kaiser, U., Uebelacker, I., Abel, U. R., Birkmann, J., Trümper, L. H. P., Schmalenberg, H., Karakas, T., Metzner, B., HOSSFELD, D. K., Bischoff, H. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.075 · Cited by 139
Corradini, P., Ladetto, M., Zallio, F., Astolfi, M., Rizzo, E., Sametti, S., Cuttica, A., Rosato, R., Farina, L., Boccadoro, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.054 · Cited by 126
Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous
Xing, X., & Feldman, A. L. (2014) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000047 · Cited by 117
Role of Positron Emission Tomography in Lymphoma
Juweid, M. E., & Cheson, B. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.904 · Cited by 115
Kewalramani, T., Nimer, S. D., Zelenetz, A. D., Malhotra, S., Qin, J., Yahalom, J., & Moskowitz, C. H. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704214 · Cited by 113
Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms
Franceschi, S., Maso, L. D., & Vecchia, C. L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<481::aid-ijc8>3.0.co;2-5 · Cited by 111
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Touroutoglou, N., Dimopoulos, M. A., Younes, A. I. A., Hess, M., Pugh, W. C., Cox, J. D., Cabanillas, F., & Sarris, A. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1361 · Cited by 105
Lee, E. J., Petroni, G. R., Schiffer, C. A., Freter, C. E., Johnson, J. L., Barcos, M. P., Frizzera, G., Bloomfield, C. D., & Peterson, B. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4014 · Cited by 104
Liedtke, M., Hamlin, P. A., Moskowitz, C. H., & Zelenetz, A. D. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl049 · Cited by 103
PET Scans in the Staging of Lymphoma: Current Status
Friedberg, J. W., & Chengazi, V. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-438 · Cited by 96
Richardson, M., Chen, Q., Filippa, D. A., Offit, K., Hampton, A., Koduru, P., Jhanwar, S., Lieberman, P., Clarkson, B., & CHAGANTI, R. S. K. (1987) · Blood · doi:10.1182/blood.v70.2.444.444 · Cited by 96
Greb, A., Bohlius, J., Schiefer, D., Schwarzer, G., Schulz, H., & Engert, A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004024.pub2 · Cited by 95
Eve, H. E., Carey, S., Richardson, S. J., et al. (2012) · British Journal of Haematology · doi:10.1111/bjh.12008 · Cited by 95
T-Cell/Histiocyte-Rich B-Cell Lymphoma: Biology, Diagnosis, and Management
Abramson, J. S. (2006) · The Oncologist · doi:10.1634/theoncologist.11-4-384 · Cited by 94
Stone, R. M. (1994) · Blood · doi:10.1182/blood.v83.12.3437.bloodjournal83123437 · Cited by 89
Combination sequential chemotherapy in advanced reticulum cell sarcoma
Levitt, M., Marsh, J. C., DeConti, R. C., Mitchell, M. S., Skeel, R. T., Farber, L. R., & Bertino, J. R. (1972) · Cancer · Cited by 83
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis
Khabori, M. A., de Almeida, J. R., Guyatt, G. H., Kuruvilla, J. G., & Crump, M. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr450 · Cited by 83
O’Connor, O. A., Moskowitz, C. H., Portlock, C. S., Hamlin, P. A., Straus, D. J., Dumitrescu, O., Sarasohn, D. M. M., Gönen, M., Butos, J. N., Neylon, E., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07466.x · Cited by 82
Kusnierz-Glaz, C. R., Schlegel, P. G., Wong, R. M., Schriber, J., Chao, N. J. A., Amylon, M. D., Hu, W. W., Negrin, R. S., Lee, Y., Blume, K. G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.18 · Cited by 78
Staratschek‐Jox, A., Wolf, J., & Diehl, V. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46877-8_11 · Cited by 58
Pfreundschuh, M. G., Kloess, M., Schmits, R., et al. (2005) · Blood · doi:10.1182/blood.v106.11.13.13 · Cited by 56
β-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas
Johnson, P., Whelan, J. S., Longhurst, S., Stepniewska, K., Matthews, J., AMESS, J. A. L., Norton, A. J., Rohatiner, A., & Lister, T. A. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.144 · Cited by 54
Toze, C. L., Barnett, M. J., Connors, J. M., Gascoyne, R. D., Voss, N., Nantel, S. H., Nevill, T. J., Shepherd, J. D., Sutherland, H. J., Lavoie, J. C., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05194.x · Cited by 51
Wagner, L. I., Zhao, F., Hong, F., Williams, M. E., Gascoyne, R. D., Krauss, J. C., Advani, R. H., Go, R. S., Habermann, T. M., Leach, J. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.6801 · Cited by 40
Richterʼs Syndrome: Biology and Therapy
Yee, K. W. L., OʼBrien, S. M., & Giles, F. J. (2005) · The Cancer Journal · doi:10.1097/00130404-200505000-00001 · Cited by 27
Ladetto, M., Vallet, S., Benedetti, F. M., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404346 · Cited by 19
Cited by
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05435-1 · Cited by 571
Imaging in staging of malignant lymphoma: a systematic review
Kwee, T. C., Kwee, R. M., & Nievelstein, R. A. J. (2008) · Blood · doi:10.1182/blood-2007-07-101899 · Cited by 264
Metadata
- Authors
- Ansell, S. M., & Armitage, J.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 80
- Issue
- 8
- Pages
- 1087-1097
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2106294189
- Cited by
- 356
- References
- 197
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.